Other

Pfizer sees Covid-19 drug sales topping $50 bn in 2022

Pfizer forecast more than $50 billion in 2022 sales for its Covid-19 vaccine and therapeutic on Tuesday as the pharmaceutical giant reported a more than doubling of annual profits on strong sales of its innoculation.

Vaccination

Germany getting more vaccines for 'offensive' booster drive

Germany is scrambling to procure more vaccines to fuel what the new health minister on Thursday called a "very offensive" and fast booster strategy that would leave the country better prepared for the onslaught of the new ...

Vaccination

Germany's CureVac ditches first-generation COVID jab

Germany's CureVac said Tuesday it is no longer seeking European regulatory approval for its coronavirus vaccine, and will focus instead on a more promising second-generation jab.

Diseases, Conditions, Syndromes

Paving the way for an Ebola-free West Africa

The 2014–2016 Ebola virus epidemic in West Africa was the worst outbreak of the disease since its discovery in the 1970s. Centered in Guinea, Liberia and Sierra Leone, the epidemic claimed over 11 300 lives—more than ...

Vaccination

Haiti awaits first vaccines amid delays, renewed promises

Officials offered new promises Thursday that Haiti would soon receive its first vaccine as the country of more than 11 million people reels from a spike in coronavirus cases and COVID-19 deaths that have saturated hospitals.

Vaccination

EU watchdog to rule Friday on Pfizer for youths

The European Medicines Agency will announce on Friday whether it has approved the Pfizer/BioNTech coronavirus jab for 12- to 15-year-olds, the regulator said.

page 3 from 7